ILC Therapeutics Ltd
www.ilctherapeutics.comILC Therapeutics™ Ltd is an early stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics. We have several patents in this area and our two lead compounds: ILCT 1001 and ILCT 1002 have been shown in numerous ways to affect the key cells involved in cancer, atopic dermatitis, and psoriasis.
Read more
ILC Therapeutics™ Ltd is an early stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics. We have several patents in this area and our two lead compounds: ILCT 1001 and ILCT 1002 have been shown in numerous ways to affect the key cells involved in cancer, atopic dermatitis, and psoriasis.
Read more
Country
Industry
Employees
1-10
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Financial Officer
Email ****** @****.comPhone (***) ****-****Finance Director
Email ****** @****.comPhone (***) ****-****Non Executive Director
Email ****** @****.comPhone (***) ****-****Head of Technical Operations
Email ****** @****.comPhone (***) ****-****
Technologies
(3)
